Synapse - Mark Dickson

Results (169)

High-risk features in radiation-associated breast angiosarcomas

Journal Article

D'Angelo, S. P.; Antonescu, C. R.; Kuk, D.; Qin, L.; Moraco, N.; Carvajal, R. D.; Chi, P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; more...
British Journal of Cancer (2013)

Fulltext@MSK | Save

Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience

Journal Article

Luke, J. J.; Callahan, M. K.; Postow, M. A.; Romano, E.; Ramaiya, N.; Bluth, M.; Giobbie-Hurder, A.; Lawrence, D. P.; Ibrahim, N.; Ott, P. A.; more...
Cancer (2013)

Fulltext@MSK | Save

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma

Journal Article

Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; Condy, M. M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Ipilimumab for patients with advanced mucosal melanoma

Journal Article

Postow, M. A.; Luke, J. J.; Bluth, M. J.; Ramaiya, N.; Panageas, K. S.; Lawrence, D. P.; Ibrahim, N.; Flaherty, K. T.; Sullivan, R. J.; Ott, P. A.; more...
The Oncologist (2013)

Fulltext@MSK | Save

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial

Journal Article

Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S. M.; Reed, D. R.; Okuno, S. H.; more...
Lancet Oncology (2013)

Fulltext@MSK | Save

Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: Clinical and molecular correlates

Journal Article

Dickson, M. A.; Schwartz, G. K.; Antonescu, C. R.; Kwiatkowski, D. J.; Malinowska, I. A.
International Journal of Cancer (2013)

Fulltext@MSK | Save

Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors

Journal Article

Dickson, M. A.; Okuno, S. H.; Keohan, M. L.; Maki, R. G.; D'adamo, D. R.; Akhurst, T. J.; Antonescu, C. R.; Schwartz, G. K.
Annals of Oncology (2013)

Fulltext@MSK | Save

Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)

Meeting Abstract

Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

A first-in-human, phase Ib combination study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of a hedgehog inhibitor, GDC-0449, with a Notch inhibitor, RO4929097, in patients with advanced sarcoma